Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome

被引:211
作者
Cibula, D
Cífková, R
Fanta, M
Poledne, R
Zivny, J
Skibová, J
机构
[1] Charles Univ, Gen Teaching Hosp, Dept Obstet & Gynecol, Prague 12000 2, Czech Republic
[2] Inst Clin & Expt Med, Dept Prevent Cardiol, Prague 14021 4, Czech Republic
[3] Inst Clin & Expt Med, Dept Stat, Prague 14021 4, Czech Republic
[4] Inst Clin & Expt Med, Lab Atherosclerosis Res, Prague 14021 4, Czech Republic
关键词
coronary artery disease; late risks; NIDDM; PCOS;
D O I
10.1093/humrep/15.4.785
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The aim of the study was to determine the prevalence of non-insulin dependent diabetes mellitus (NIDDM), arterial hypertension, coronary artery disease and the risk factors for these diseases in perimenopausal women with a history of polycystic ovary syndrome (PCOS) treatment, A group of 28 women was selected from a large group of patients who had undergone wedge ovarian resection. A total of 752 controls was selected by age (45-59 years) from a random female population sample. There was no difference between the two groups in body mass index, waist circumference or waist-hip ratio. Both groups were found to have identical family histories of NIDDM, hypertension, and coronary artery disease and identical smoking habits, We did not find a difference between the mean concentrations of lipids and fasting glucose. The two groups did not differ in the proportions of women with elevated lipid concentrations. The prevalence of NIDDM and coronary artery disease was significantly higher in PCOS women. In conclusion, women in the general population have the same level of risk factors at perimenopausal age as PCOS women. Patients with markedly expressed clinical symptoms of PCOS made up a subgroup in the general population at high risk for developing NIDDM and coronary artery disease.
引用
收藏
页码:785 / 789
页数:5
相关论文
共 26 条
[1]   The plasminogen activator system in women with polycystic ovary syndrome [J].
Atiomo, WU ;
Bates, SA ;
Condon, JE ;
Shaw, S ;
West, JH ;
Prentice, AG .
FERTILITY AND STERILITY, 1998, 69 (02) :236-241
[2]   CLINICAL IMPLICATIONS OF HYPERINSULINEMIA IN WOMEN [J].
CONWAY, GS ;
JACOBS, HS .
CLINICAL ENDOCRINOLOGY, 1993, 39 (06) :623-632
[3]  
DAHLGREN E, 1994, FERTIL STERIL, V61, P455
[4]  
DAHLGREN E, 1992, FERTIL STERIL, V57, P505
[5]   beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome [J].
Dunaif, A ;
Finegood, DT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :942-947
[6]   CHARACTERIZATION OF GROUPS OF HYPERANDROGENIC WOMEN WITH ACANTHOSIS NIGRICANS, IMPAIRED GLUCOSE-TOLERANCE, AND - OR HYPERINSULINEMIA [J].
DUNAIF, A ;
GRAF, M ;
MANDELI, J ;
LAUMAS, V ;
DOBRJANSKY, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (03) :499-507
[7]   Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus [J].
Ehrmann, DA .
BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1997, 11 (02) :335-347
[8]   INSULIN SECRETORY DEFECTS IN POLYCYSTIC-OVARY-SYNDROME - RELATIONSHIP TO INSULIN SENSITIVITY AND FAMILY HISTORY OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
EHRMANN, DA ;
STURIS, J ;
BYRNE, MM ;
KARRISON, T ;
ROSENFIELD, RL ;
POLONSKY, KS .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :520-527
[9]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]   Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control study [J].
Guzick, DS ;
Talbott, EO ;
SuttonTyrrell, K ;
Herzog, HC ;
Kuller, LH ;
Wolfson, SK .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (04) :1224-1229